Marshall Wace, LLP Vericel Corp Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $435,963 - $701,535	13,406 New	13,406 $697,000
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $5.45 Million - $7.21 Million	-187,866 Reduced 87.23%	27,495 $1.03 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $5.14 Million - $6.75 Million	215,361 New	215,361 $6.31 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $2.95 Million - $4.25 Million	130,485 Added 109.81%	249,317 $5.78 Million
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $611,262 - $1.05 Million	-26,716 Reduced 18.36%	118,832 $2.99 Million
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $4.52 Million - $6.17 Million	142,517 Added 4701.98%	145,548 $5.56 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $106,691 - $159,430	3,031 New	3,031 $119,000
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $5.31 Million - $9.02 Million	-286,430 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $2.28 Million - $2.97 Million	-155,214 Reduced 35.14%	286,430 $5.31 Million
Q2 2020 Aug 13, 2020	SELL	$8.5 - $15.82 $2.16 Million - $4.02 Million	-253,920 Reduced 36.51%	441,644 $6.1 Million
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $4.03 Million - $10.7 Million	555,810 Added 397.71%	695,564 $6.38 Million
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $1.92 Million - $2.68 Million	139,754 New	139,754 $2.43 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $2.74 Million - $3.45 Million	-182,791 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$16.23 - $20.29 $2.97 Million - $3.71 Million	182,791 New	182,791 $3.2 Million
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $5.91 Million - $10.1 Million	-548,751 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $4.12 Million - $6.7 Million	452,714 Added 471.4%	548,751 $7.77 Million
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $921,955 - $1.4 Million	96,037 New	96,037 $932,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.5M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account